Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer

Steven A. Rosenberg, Michael T. Lotze, James C. Yang, Suzanne L. Topalian, Alfred E. Chang, Douglas J. Schwartzentruber, Paul Aebersold, Susan Leitman, W. Marston Linehan, Claudia A. Seipp, Donald E. White, Seth M. Steinberg

Research output: Contribution to journal › Article › peer-review

523 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences